Fern M. Anari, MD

Dr. Fern Anari

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Secondary Location

Fox Chase Cancer Center East Norriton-Hospital Outpatient Center
2701 Dekalb Pike
East Norriton, PA 19401


Assistant Professor, Department of Hematology/Oncology

Treatment Focus

Chemotherapy, targeted therapy, immunotherapy, hormone therapy, clinical trials for genitourinary malignancies

Treatment Philosophy

I am a medical oncologist specializing in cancers of the genitourinary tract. A new cancer diagnosis can be both overwhelming and life-changing for patients and their loved ones. As a medical oncologist, it is my privilege to help patients navigate this new world by not only helping them understand their diagnosis and treatment options, but also by providing support and guidance along the way. Every patient has a unique experience, so it is important for me to build a relationship with each person I meet so I can best understand his or her values in order to treat each person as a whole. My patients are my number one priority. It is my mission to make sure any and all questions are answered, and that patients and their families feel comfortable with every decision made throughout their journey. 

At Fox Chase Cancer Center, I am lucky to work as part of a multidisciplinary team alongside other medical oncologists, urologists, radiation oncologists and other cancer specialists, which allows me to provide the highest quality of care in a personalized manner tailored to each patient. Being a part of Fox Chase allows me to offer patients both standard-of-care treatments and new, cutting edge treatment options through clinical trial participation. The field of medical oncology is rapidly evolving and Fox Chase is on the forefront of these exciting changes.     

Education and Training

Educational Background

  • Fellowship, Hematology/Medical Oncology, Fox Chase Cancer Center/Temple University Hospital, Philadelphia, PA
  • Residency, Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
  • MD, Rutgers/Robert Wood Johnson Medical School, New Brunswick, NJ


  • American Board of Internal Medicine, Medical Oncology, 2019
  • American Board of Internal Medicine, Hematology, 2019
  • American Board of Internal Medicine, Internal Medicine, 2016


  • American Society of Clinical Oncology
  • American Society of Hematology
  • Alpha Omega Alpha Honor Medical Society

Honors & Awards

  • American Medical Women's Association Glasgow-Rubin Citation for Academic Achievement, 2013
  • Angelo P. Angelides Award for Academic Excellence in Medicine, 2013



Selected Publications

  • Winer A, Ghatalia P, Bubes N, Anari F, Varshavsky A, Kasireddy V, Liu Y, El-Deiry WS. Dual checkpoint inhibition with ipilimumab plus nivolumab after progression on sequential PD-1/PDL-1 inhibitors pembrolizumab and atezolizumab in a patient with Lynch Syndrome, metastatic colon and localized urothelial cancer. The Oncologist.
  • Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Saltzberg PD, Bubes N, Anari F, Kasireddy V, Varshavsky A, Liu Y, Ross E, El-Deiry WS. Clinical use of liquid biopsies to detect actionable driver mutations, guide treatment decisions and monitor disease burden during treatment of 33 metastatic colorectal cancer patients at Fox Chase Cancer Center GI Oncology subspecialty clinic. Frontiers in Oncology. 2019 Jan, 8(1-8).    
  • Anari F, Dotan E. Management of Older Adults with Colorectal Cancer. Hospital Physician Hematology/Oncology Board Review Manual. 2018,13(4):7-22. 
  • Anari F, Ramamurthy C, Zibelman M. Impact of Tumor Microenvironment Composition on Therapeutic Responses and Clinical Outcomes in cancer. Future Oncology. 2018 Jun;14(14):1409-1421.
  • Anari F, O’Neill J, Choi W, Chen D, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg R, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas C, Trabulsi E, Smaldone M, Geynisman D, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER. Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Muscle-Invasive Bladder Cancer: Results of a Phase 2 Trial. European Urology Oncology. 2018 May;1(1):54-60.


Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.


4.9 / 5.0


  • 4.8
  • 4.9
  • 5.0
  • 5.0
  • 4.9


  • 5.0
    June 19, 2022
    They were kind to me and extremely understanding and informative
  • 5.0
    May 23, 2022
    Doctors well caring.
  • 5.0
    May 02, 2022
    Every time I come to Fox Chase, everyone there treats me like royalty! My hat is off to them.
  • 5.0
    April 15, 2022
  • No Star Ratings Available March 21, 2022
    Dr Anari was extremely helpful and had reviewed my case. She explained everything to me clearly..
  • 5.0
    March 21, 2022
    I am blessed to have Dr. Anari as my oncologist! [...]
  • 5.0
    March 18, 2022
    All good, no bad, except for the commute.
  • No Star Ratings Available March 06, 2022
    Always a good experience. Very thorough discussion and attention to every issue. The best think I did was choose my care at Fox Chase.
  • No Star Ratings Available February 09, 2022
    Doctor was extremely helpful and caring.
  • 5.0
    January 24, 2022
    Dr. Anari and her team were great!!!
  • 5.0
    January 10, 2022
    Dr. Anari & Fox Chase is doing their best to keep me alive.
  • 5.0
    January 05, 2022
    I have always been treated with respect & concern for my health. Everyone is always caring & competent.
  • 5.0
    November 15, 2021
    Dr. Fern Anari very professional.
  • 5.0
    October 28, 2021
    Dr. Anari was prepared and knew my case history. She gave me sound advice about medications I am currently taking. She also talked about future follow-ups. She impressed me as knowledgeable, caring and willing to listen to my concerns. She made me feel comfortable.
  • No Star Ratings Available October 28, 2021
    She demonstrated knowledge of my case, was very prepared and concerned with presenting accurate and helpful information.
  • No Star Ratings Available July 28, 2021
    Dr. Anari is an excellent physician in my opinion.
  • 5.0
    April 05, 2021
    Dr. Anari & staff are AMAZING! Best thing to happen to me now!
  • 5.0
    April 01, 2021
    1 yr. ago I was diagnosed with prostate cancer. Today thanks to Dr. Anari she has made me feel a lot better about my cancer. I don't think about it as often. She's the best!
  • No Star Ratings Available March 14, 2021
    explained everything in a way that was understandable
  • 5.0
    February 09, 2021
    Always a great visit with Dr. Anari.

Connect with Fox Chase